Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madsbad

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Diabetes, Obesity & Metabolism|July 24, 2010
Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetesR Rabøl, R Boushel, T Almdal, et al.
Clinical Endocrinology|June 1, 1982
The significance of the portal insulin secretion in insulin dependent patients with residual beta-cell function: a safeguard against hormonal and metabolic derangementS Madsbad, O K Faber, A Kurtz, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adultsA M Rosenfalck, S Maghsoudi, S Fisker, et al.
Transplantation Proceedings|April 1, 1994
Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas TransplantationE Christiansen, A Tibell, C G Groth, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 3, 2009
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetesJ-P Courrèges, T Vilsbøll, M Zdravkovic, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotypeT Vilsbøll, F K Knop, T Krarup, et al.
HIV Medicine|April 6, 2005
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapyO Andersen, S B Haugaard, J J Holst, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetesM H Tan, D Johns, J Strand, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Pancreatic endocrine function in recipients of segmental and whole pancreas transplantationE Christiansen, A Tibell, A Vølund, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patientsM B Toft-Nielsen, M B Damholt, S Madsbad, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Diabetes, Obesity & Metabolism|July 24, 2010
Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetesR Rabøl, R Boushel, T Almdal, et al.
Clinical Endocrinology|June 1, 1982
The significance of the portal insulin secretion in insulin dependent patients with residual beta-cell function: a safeguard against hormonal and metabolic derangementS Madsbad, O K Faber, A Kurtz, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adultsA M Rosenfalck, S Maghsoudi, S Fisker, et al.
Transplantation Proceedings|April 1, 1994
Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas TransplantationE Christiansen, A Tibell, C G Groth, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 3, 2009
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetesJ-P Courrèges, T Vilsbøll, M Zdravkovic, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotypeT Vilsbøll, F K Knop, T Krarup, et al.
HIV Medicine|April 6, 2005
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapyO Andersen, S B Haugaard, J J Holst, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetesM H Tan, D Johns, J Strand, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Pancreatic endocrine function in recipients of segmental and whole pancreas transplantationE Christiansen, A Tibell, A Vølund, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patientsM B Toft-Nielsen, M B Damholt, S Madsbad, et al.
Pageof 23